[HTML][HTML] TGFβ drives metabolic perturbations during epithelial mesenchymal transition in pancreatic cancer: TGFβ induced EMT in PDAC
Simple Summary Pancreatic cancer is an aggressive disease with most patients diagnosed
at late stages resulting in poor outcomes. While it is known that pancreatic tumor cells …
at late stages resulting in poor outcomes. While it is known that pancreatic tumor cells …
[HTML][HTML] TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC
MU Rajagopal, S Bansal, P Kaur, SK Jain, T Altadil… - Cancers, 2021 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy wherein a majority
of patients present metastatic disease at diagnosis. Although the role of epithelial to …
of patients present metastatic disease at diagnosis. Although the role of epithelial to …
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC
MU Rajagopal, S Bansal, P Kaur, SK Jain… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy wherein a majority
of patients present metastatic disease at diagnosis. Although the role of epithelial to …
of patients present metastatic disease at diagnosis. Although the role of epithelial to …
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC.
MU Rajagopal, S Bansal, P Kaur, SK Jain… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Pancreatic cancer is an aggressive disease with most patients
diagnosed at late stages resulting in poor outcomes. While it is known that pancreatic tumor …
diagnosed at late stages resulting in poor outcomes. While it is known that pancreatic tumor …
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC.
MU Rajagopal, S Bansal, P Kaur, SK Jain, T Altadil… - Cancers, 2021 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy wherein a majority
of patients present metastatic disease at diagnosis. Although the role of epithelial to …
of patients present metastatic disease at diagnosis. Although the role of epithelial to …
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC
MU Rajagopal, S Bansal, P Kaur, SK Jain, T Altadil… - Cancers, 2021 - escholarship.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy wherein a majority
of patients present metastatic disease at diagnosis. Although the role of epithelial to …
of patients present metastatic disease at diagnosis. Although the role of epithelial to …
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC
MU Rajagopal, S Bansal, P Kaur, SK Jain, T Altadil… - …, 2021 - search.proquest.com
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy wherein a majority
of patients present metastatic disease at diagnosis. Although the role of epithelial to …
of patients present metastatic disease at diagnosis. Although the role of epithelial to …
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC.
MU Rajagopal, S Bansal, P Kaur, SK Jain, T Altadil… - Cancers, 2021 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy wherein a majority
of patients present metastatic disease at diagnosis. Although the role of epithelial to …
of patients present metastatic disease at diagnosis. Although the role of epithelial to …